Eugene

[email protected]

LATEST

Pfizer, Akcea in $1.3-Billion-Plus Pact for Investigative Antisense Therapy
By

By
Pfizer and Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, specializing in drugs for rare diseases, have entered into an exclusive license agreement for AKCEA-ANGPTL3-LRx, an investigational antisense therapy for patients…

J&J Expands Biomanufacturing Site in Ireland
By

By
Janssen Sciences Ireland, part of Johnson & Johnson, has opened a new 19,100-square-meter building for biomanufacturing in Ringaskiddy, County Cork, Ireland. The company has operated a biopharmaceutical supply chain facility…

Global Pharma Briefs: News from Europe, Asia and the Middle East
By

By
A roundup of developments and latest news from China (Eisai and Nichi-Iko Pharmaceutical), Israel (Teva) and the UK and Germany (AstraZeneca and Cheplapharm). China Eisai and Nichi-Iko Partner for Generic…

Novartis, Microsoft Partner in Artificial Intelligence for Drug Development
By

By
Novartis has announced that it is collaborating with Microsoft to create the Novartis AI innovation lab and has selected Microsoft as its strategic artificial intelligence (AI) and data-science partner. Novartis…

J&J Reaches $20-Million Settlement in Opioid Litigation
By

By
Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies have reached a settlement agreement on pending opioid litigation with the Ohio counties of Cuyahoga and Summit that resolves all of…

FDA, EMA Provide Updates on Investigation of Ranitidine Products
By

By
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have provided updates of their respective investigations into the detection of certain nitrosamine impurities regarded as probable…

GSK, Novartis, Apotex Issue Recalls of Ranitidine Products; Walmart, CVS Suspend Sales
By

By
In light of ongoing investigations by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) over the detection of nitrosamine impurities in ranitidine, an over-the-counter (OTC)…

Thermo Fisher Scientific Expanding API Ops; Investing $270 Million More in Other Capabilities
By

By
Thermo Fisher Scientific has announced an expansion of its active pharmaceutical ingredient (API) manufacturing capabilities following the completion of its previously announced EUR 90-million ($100.6 million) acquisition of an API…

Sobi To Acquire Dova Pharmaceuticals in $915-Million Deal
By

By
Swedish Orphan Biovitrum (Sobi), a Stockholm, Sweden-based pharmaceutical company specializing in treatments for rare diseases, has agreed to acquire Dova Pharmaceuticals, a Durham, North Carolina-based clinical-stage biopharmaceutical company, by means…

Roche Extends Tender Offer in $4.3-Billion Acquisition of Spark Therapeutics
By

By
Roche has extended its tender offer period relating to its pending $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company, from October 1, 2019 to October 30, 2019. Roche had…